Document Detail


Hodgkin's disease: a disorder of dysregulated cellular cross-talk.
MedLine Citation:
PMID:  9592019     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hodgkin's disease (HD) is a peculiar type of human malignant lymphoma characterized by a very low frequency of tumor cells, the so called Hodgkin and Reed-Sternberg (H-RS) cells, embedded in a hyperplastic background of non-neoplastic (reactive) cells recruited and activated by H-RS cells-derived cytokines. H-RS cells can be functionally regarded as antigen-presenting cells (APC) able to elicit an intense, but anergic and ineffective, T-cell mediated immune response along with a hyperplastic inflammatory reaction which involves several cell types including T- and B-cells, neutrophils, eosinophils, plasma cells, fibroblasts and stromal cells. In tissues involved by HD, malignant H-RS cells and their reactive neighboring cells are able to cross-talk via a complex network of cytokine- and cell contact-dependent interactions. As a result of such interactions, mediated by specific surface receptors and adhesion molecules on both tumor and non-neoplastic cells, H-RS cells may receive several proliferative and anti-apoptotic signals favoring the cellular expansion and tumor cell survival in HD. The ineffective T-cell immune response elicited by the abnormal APC function of H-RS cells may further contribute to the biologic and clinical progression of HD. Innovative therapeutic strategies aimed at blocking the pathways of dysregulated cellular cross-talk among H-RS cells and bystander reactive cell populations might be beneficial in the treatment of HD patients.
Authors:
A Pinto; V Gattei; V Zagonel; D Aldinucci; M Degan; A De Iuliis; F M Rossi; F Tassan Mazzocco; C Godeas; M Rupolo; D Poletto; A Gloghini; A Carbone; H J Gruss
Related Documents :
21528199 - Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells.
2012999 - B-cell monoclonal antibodies and their use in clinical oncology.
19867559 - Some observations of the thoracic duct lymph after injection of oil of turpentine into ...
3421009 - Cytologic study of tissue repair in human bronchial epithelium.
1710419 - Immunocytochemical panel for the identification of malignant cells in serous effusions.
15131899 - Fractal dimension in aspiration cytology smears of breast and cervical lesions.
17396239 - The plant cell nucleus is constantly alert and highly sensitive to repetitive local mec...
20197399 - Anacardic acid inhibits estrogen receptor alpha-dna binding and reduces target gene tra...
8871539 - A rapid and sensitive fluorometric screening assay using yo-pro-1 to quantify tumour ce...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Biotherapy (Dordrecht, Netherlands)     Volume:  10     ISSN:  0921-299X     ISO Abbreviation:  Biotherapy     Publication Date:  1998  
Date Detail:
Created Date:  1998-06-26     Completed Date:  1998-06-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8903031     Medline TA:  Biotherapy     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  309-20     Citation Subset:  IM    
Affiliation:
The Leukemia Unit, I.R.C.C.S., Aviano, Italy. apinto@ets.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Communication / physiology*
Hodgkin Disease / pathology*
Humans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hematopoietic growth factors in autologous transplantation.
Next Document:  Natural and therapeutically-induced antibodies to cytokines.